Market Research Report
Global Anal Fistula Therapeutics Market 2020-2026
|Published by||Orion Market Research Pvt Ltd||Product code||949663|
Delivery time: 2-3 business days
|Global Anal Fistula Therapeutics Market 2020-2026|
|Published: June 27, 2020||Content info:||
Global Anal Fistula Therapeutics Market Size, Share & Trends Analysis Report, By Treatment (Surgical and Non-Surgical), By Application (Intersphincteric Fistula, Transsphincteric Fistula, Suprasphincteric Fistula, and Others), By End-User (Hospitals, Ambulatory Surgical Centers, and Others) and Forecast, 2020-2026
The global anal fistula therapeutics market is estimated to grow significantly during the forecast period. The significant prevalence of IBD is primarily driving the growth of the market. Emerging non-surgical alternatives is expected to offer an opportunity for market growth. Fibrin glue and Alofisel (darvadstrocel) are the non-surgical alternatives available in the market for the treatment of anal fistula. Fibrin glue involves injecting a glue by the surgeon into the fistula when the patient is under general anaesthetic. This glue enables to seal the fistula and supports it to heal. It is usually less effective compared to fistulotomy for simple fistulas.
Its results may not last for a longer period; however, it may be a helpful alternative for fistulas that pass through the anal sphincter muscles as the cut is not required there. Alofisel (darvadstrocel) is the first stem cell therapy to treat complex perianal fistulas in adult patients suffering from nonactive/mildly active luminal Crohn's disease when fistulas have shown an insufficient response to at least one traditional or biologic therapy. More non-surgical alternatives are expected to be introduced in the future, which will likely present a significant opportunity for the growth of the market.
Geographically, in 2019, North America held the largest share in the market owing to the rising prevalence of IBD and considerable health awareness in the region. As per the Centers for Disease Control and Prevention (CDC), in 2015, nearly 1.3% of the US adults (3 million) were reported being diagnosed with IBD (either ulcerative colitis or Crohn's disease). Increased chances of developing fistulas occur when the organ becomes inflamed or injured, which is a common complication of IBD, found most frequently in Crohn's disease than ulcerative colitis. Therefore, the rising prevalence of IBD is contributing to the growth of the market.
Some key players in the market include Medtronic plc, Karl Storz SE & Co. KG, Cook Group Inc., Takeda Pharmaceutical Co. Ltd., and Signum Surgical Ltd. Medtronic offers Permacol collagen paste, which is a minimally invasive treatment for anal fistula. It is made of porcine dermal, acellular collagen suspended in saline. It may be utilized as a single treatment alternative or in combination with other treatment including the ligation of intersphincteric fistula tract (LIFT) technique. Signum Surgical developed the BioHealx device, for improvement in surgical procedures to fulfil all identified essential clinical requirements for reliable healing of heal anal fistulas.
The market study of the global anal fistula therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
The Report Covers: